Gastric cancer survivors should be aware of osteoporosisJanuary 17, 2008Gastric cancer is one of the most common cancers in the world. Although the prognosis of gastric cancer is known to be poor, the survival rate for those who receive operative treatment is increasing recently by virtue of early diagnosis and aggressive surgical intervention. However, many surviving patients might suffer from osteoporosis and be at risk of developing multiple fractures in their later life. A research article published on December 28, 2007 in the World Journal of Gastroenterology (volume 13, issue 48) addresses this problem. The Korea Cancer Center Hospital research team, led by Dr. Jong-Inn Lee who is the president of Korea Gastric Cancer Association, reported the prevalence of osteoporosis in patients who survived after gastrectomy was 38.3%, vertebral deformity rate was 46.6% and 45.9% of patients complained of bone related pain. One possible reason for the high prevalence of osteoporosis reported by the investigators is that the average age of gastrectomy in gastric cancer patients is about 60 years, and being older than 64 years was an independent predicting factor of osteoporosis. Another possible reason is gastrectomy might affect calcium and other nutrient absorption, as most patients with osteoporosis had anemia and decreased body mass index. The authors recommend all patients who have anemia, back pain, or are over 60 years be screened for osteoporosis by Dual-energy X-ray absorptiometry (DXA), regardless of tumor stage and type of reconstruction. World Journal of Gastroenterology |
|||||||||||||||||||||
| Related Gastric Cancer Current Events and Gastric Cancer News Articles Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis? Since the isolation and culture of Helicobacter pylori (H. pylori) in 1983, this bacterium has become accepted as an important human pathogen for the development of gastritis, peptic ulcer, and gastric cancer. A new explanation of 'Asian paradox' Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Will genomics help prevent the next pandemic? This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease. Protein interaction network can respond Helicobacter pylori infection? Helicobacter pylori (H pylori) is a gram negative bacterium which infects about 50% of the world population. H pylori colonization causes a strong systemic immune response. A case of post-gastrectomy acute pancreatitis Gastrectomy is commonly performed for both benign and malignant lesions. Although the incidence of post-gastrectomy acute pancreatitis (PGAP) is low compared to other well-recognized post-operative complications, it has been reported to be associated with a high mortality rate. Does Helicobacter pylori eradication therapy prevent gastric cancer? Although it has been demonstrated that Helicobacter pylori causes gastric cancer, it is still controversial that whether H. pylori eradication therapy is effective in primary prevention of gastric cancer. New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress. NIH study reveals new genetic culprit in deadly skin cancer Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. PPAR-g agonists have potential therapeutic role in gastric carcinoma? Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied. D2 lymphadenectomy improves the long-term survival for patients with node-negative gastric cancer Many studies favor an extended lymphadenectomy at the time of a potentially curative gastrectomy for node-positive gastric cancer, and the risk of long-term death tends to decrease when the number of resected lymph nodes increases to about 25. More Gastric Cancer Current Events and Gastric Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||